Donald L. Morton
- Oncology top 0.01%
- Molecular Biology top 0.2%
- Immunology top 0.1%
- Epidemiology top 0.1%
- Cancer Research top 0.2%
- Co-authors
- Frederick R. EilberAlistair J. CochranJohn F. ThompsonRichard EssnerDave S.�B. HoonRobert M. ElashoffReiko F. IrieKelly M. McMasters
- Topics
- Immunotherapy and Immune Responses (160 papers)Cutaneous Melanoma Detection and Management (127 papers)Cancer Immunotherapy and Biomarkers (63 papers)
- Cited by
- OncologyImmunologyDermatology
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Donald L. Morton
441 papers receiving 31.7k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Oncology 22.7k
- Molecular Biology 10.4k
- Immunology 8.8k
- Epidemiology 6.8k
- Cancer Research 4.0k
Countries citing papers authored by Donald L. Morton
This map shows the geographic impact of Donald L. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald L. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald L. Morton more than expected).
Fields of papers citing papers by Donald L. Morton
This network shows the impact of papers produced by Donald L. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald L. Morton. The network helps show where Donald L. Morton may publish in the future.
Co-authorship network of co-authors of Donald L. Morton
This figure shows the co-authorship network connecting the top 25 collaborators of Donald L. Morton. A scholar is included among the top collaborators of Donald L. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald L. Morton. Donald L. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 250 | |
| 3 | 287 | |
| 4 | 75 | |
| 5 | Final Version of 2009 AJCC Melanoma Staging and Classificationbreakdown → | 3342 |
| 6 | 157 | |
| 7 | 93 | |
| 8 | 114 | |
| 9 | Low lymph flow decreases with age and correlates with non-sentinel node metastases and poor survival in stage III melanoma | 1 |
| 10 | 13 | |
| 11 | 93 | |
| 12 | 53 | |
| 13 | Xeroradiography of the Breast | 6 |
| 14 | 14 | |
| 15 | 9 | |
| 16 | Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography. | 14 |
| 17 | A new in vivo assay of human lymphocyte-mediated immunity to melanoma. | 3 |
| 18 | Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer. | 11 |
| 19 | Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas. | 60 |
| 20 | 82 |
About Donald L. Morton
Donald L. Morton is a scholar working on Oncology, Immunology and Immunology and Allergy, having authored 448 papers that have together received 33.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (160 papers), Cutaneous Melanoma Detection and Management (127 papers) and Cancer Immunotherapy and Biomarkers (63 papers). The work is most often cited by research in Oncology (22.7k citations), Immunology (8.8k citations) and Dermatology (3.0k citations). Donald L. Morton has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Frederick R. Eilber, Alistair J. Cochran, John F. Thompson, Richard Essner, Dave S.�B. Hoon, Robert M. Elashoff, Reiko F. Irie, Kelly M. McMasters, Jeffrey E. Gershenwald and Charles M. Balch. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.